文献速递帕金森病与运动障碍认知障碍与痴呆神经重症与神经感染

新不伦瑞克不明原因神经系统综合征的临床与神经病理评估

Clinical and Neuropathological Evaluations of the New Brunswick Neurological Syndrome of Unknown Cause.
PubMed 文献 · JAMA Neurol · 2025-05-07

该横断面研究对25例曾诊断为新不伦瑞克不明原因神经系统综合征(NSUC)的患者进行独立临床再评估或神经病理检查,所有病例均发现已知疾病,包括常见神经退行性疾病、功能性神经障碍、创伤性脑损伤和转移性癌;

要点

  • 25例NSUC患者经独立评估均确诊为已知疾病,无NSUC证据。
  • 对NSUC诊断患者应进行独立的临床再评估。

核心结论

  • 本队列无证据支持NSUC诊断,独立检查和神经病理学强烈支持存在多种神经退行性和非神经退行性疾病。

研究设计与样本

  • 横断面研究,从222例NSUC诊断患者队列中纳入25例,2020-2025年间由4名运动障碍神经科医生和2名行为神经科医生在加拿大新不伦瑞克省和安大略省2家医院进行临床评估,神经病理诊断由安大略省一名神经病理学家和一名复审者盲法复核。

主要发现

  • 105例 eligible 患者中,14例(年龄20-55岁;8女6男)接受临床评估,11例(年龄56-82岁;5女6男)获得神经病理诊断。
  • 所有25例均识别出已知疾病,包括常见神经退行性疾病、功能性神经障碍、创伤性脑损伤和转移性癌。

临床怎么用

  • 对任何被诊断为NSUC的患者,需要进行独立的临床评估。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: In 2019, an alleged "mystery" neurological illness emerged in New Brunswick, Canada. Despite extensive media attention, no case description has been published to date. OBJECTIVE: To report on 25 patients with a diagnosis of New Brunswick neurological syndrome of unknown cause (NSUC) who subsequently received a second, independent clinical reassessment or neuropathological examination between 2020 and 2025. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of cases derived from a cohort of patients (n = 222) who had received an NSUC diagnosis. Four movement disorder neurologists and 2 behavioral neurologists carried out clinical evaluations at 2 hospitals in New Brunswick and Ontario, Canada. Neuropathological diagnoses were obtained in Ontario by a neuropathologist and a second reviewer, both blinded to the case histories. Eligible patients were offered a second opinion; 4 families of deceased patients provided consent for reporting autopsies and waivers of consent were obtained for 7. EXPOSURE: NSUC as described in the case definition circulated by Public Health New Brunswick in 2021. MAIN OUTCOMES AND MEASURES: Findings from the independent clinical evaluations and diagnoses obtained through neuropathological examination. RESULTS: Among 105 eligible patients, 14 patients (aged 20-55 years; 8 female, 6 male) received clinical evaluations, and 11 patients (aged 56-82 years; 5 female, 6 male) had neuropathological diagnoses. Well-known conditions were identified in all 25 cases, including common neurodegenerative diseases, functional neurological disorder, traumatic brain injury, and metastatic cancer. Based on the 11 autopsy cases, a new disease was extremely unlikely, with a probability less than .001. When applying the 95% confidence interval for the true probability of no new disease, the data revealed a high probability between 87% and 100%. CONCLUSIONS AND RELEVANCE: There was no evidence supporting a diagnosis of NSUC in this cohort. The data inclusive of independent examinations and neuropathology strongly supported the presence of several neurodegenerative and non-neurodegenerative conditions. Unfounded concerns that a potentially fatal mystery disease, possibly induced by an environmental toxin, is causing the patients' neurological symptoms has been amplified in traditional and social media. Second, independent clinical evaluations are needed for any patient given a diagnosis of NSUC.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Bendahan N, Gautreau S, Medina Escobar A, et al. Clinical and Neuropathological Evaluations of the New Brunswick Neurological Syndrome of Unknown Cause. JAMA Neurol. 2025. PMID: 40332886. doi:10.1001/jamaneurol.2025.1718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。